加纳等国社区提供者转诊前直肠青蒿琥酯治疗的整群随机试验
在加纳、几内亚比绍、坦桑尼亚和乌干达的偏远村庄,将社区治疗提供者随机分组以提供转诊前直肠青蒿琥酯。19个月内54 013名儿童共102 504次发热发作,32%符合转诊前治疗指征,14%接受了治疗;
要点
- 转诊前治疗指征的发作约占所有发热发作的三分之一。
- 接受治疗的患者中超过三分之一有惊厥、意识改变或昏迷。
- 母亲提供治疗有效且覆盖率高于其他提供者,但总体治疗可及性低。
核心结论
- 母亲作为社区治疗提供者能有效提供转诊前直肠青蒿琥酯治疗,覆盖率高于社区卫生员。
- 转诊前治疗指征的发作占所有发热发作近三分之一,但总体治疗可及性低。
研究设计与样本
- 在加纳、几内亚比绍、坦桑尼亚和乌干达的偏远村庄开展整群随机试验,共272个村庄。
- 村庄随机分配至社区卫生员(109个)、受训母亲(112个)、受训传统治疗师(25个)或社区选定人员(26个)提供转诊前直肠青蒿琥酯。
- 通过定期入户调查发热性疾病记录符合转诊前治疗指征的发作,采用logistic回归并调整村庄间异质性。
主要发现
- 19个月内54 013名儿童发生102 504次发热发作,其中32%(31 817次)有符合转诊前治疗的指征。
- 14%(4 460名)儿童接受了治疗;接受治疗儿童中36.6%的发作有意识改变、昏迷或惊厥。
- 调整异质性后,母亲组儿童接受治疗的平均概率比社区卫生员组高1.67倍。
临床怎么用
- 在偏远地区可考虑培训母亲提供转诊前直肠青蒿琥酯以提高治疗覆盖率。
- 需关注接受转诊前治疗儿童中高比例的惊厥、意识改变或昏迷。
- 传统治疗师作为提供者可能伴随更高死亡风险,需谨慎评估。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: If malaria patients who cannot be treated orally are several hours from facilities for injections, rectal artesunate prior to hospital referral can prevent death and disability. The goal is to reduce death from malaria by having rectal artesunate treatment available and used. How best to do this remains unknown. METHODS: Villages remote from a health facility were randomized to different community-based treatment providers trained to provide rectal artesunate in Ghana, Guinea-Bissau, Tanzania, and Uganda. Prereferral rectal artesunate treatment was provided in 272 villages: 109 through community-based health workers (CHWs), 112 via trained mothers (MUMs), 25 via trained traditional healers (THs), and 26 through trained community-chosen personnel (COMs); episodes eligible for rectal artesunate were established through regular household surveys of febrile illnesses recording symptoms eligible for prereferral treatment. Differences in treatment coverage with rectal artesunate in children aged <5 years in MUM vs CHW (standard-of-care) villages were assessed using the odds ratio (OR); the predictive probability of treatment was derived from a logistic regression analysis, adjusting for heterogeneity between clusters (villages) using random effects. RESULTS: Over 19 months, 54 013 children had 102 504 febrile episodes, of which 32% (31 817 episodes) had symptoms eligible for prereferral therapy; 14% (4460) children received treatment. Episodes with altered consciousness, coma, or convulsions constituted 36.6% of all episodes in treated children. The overall OR of treatment between MUM vs CHW villages, adjusting for country, was 1.84 (95% confidence interval [CI], 1.20-2.83; P = .005). Adjusting for heterogeneity, this translated into a 1.67 higher average probability of a child being treated in MUM vs CHW villages. Referral compliance was 81% and significantly higher with CHWs vs MUMs: 87% vs 82% (risk ratio [RR], 1.1 [95% CI, 1.0-1.1]; P < .0001). There were more deaths in the TH cluster than elsewhere (RR, 2.7 [95% CI, 1.4-5.6]; P = .0040). CONCLUSIONS: Prereferral episodes were almost one-third of all febrile episodes. More than one-third of patients treated had convulsions, altered consciousness, or coma. Mothers were effective in treating patients, and achieved higher coverage than other providers. Treatment access was low. CLINICAL TRIALS REGISTRATION: ISRCTN58046240.
引用
- Warsame M, Gyapong M, Mpeka B, et al. Pre-referral Rectal Artesunate Treatment by Community-Based Treatment Providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (Study 18): A Cluster-Randomized Trial. Clin Infect Dis. 2016. PMID: 27941110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。